LiveSpo is a pioneer in R&D and manufacturing spore-based probiotics based on Bacillus Subtills and Bacillus Clausii. LiveSpo is a model of Vietnam based biotech R&D which have led to scientific breakthroughs on a global scale. A series of three clinical trials, all separately peer reviewed and published in the leading peer reviewed journal Scientific Reports, demonstrated that LiveSpo NAVAX, which utilizes bacillus subtills spores in a saline solution, applied to the respiratory tract, had a substantial impact on eliminating respiratory viral infections. This included shortened recovery times, symptom relief and significantly reduced viral load counts for acute respiratory syncytial virus (RSV), influenza, and acute rhinosinusitis (ARS) and acute otitis media (AOM). Scientific Reports is a peer-reviewed scientific journal that belongs to the Nature Portfolio, which is a group of journals owned by the publisher Springer Nature.
Gene Solutions is a pioneer in gene-based disease detection at affordable prices. Their globally cutting-edge R&D team has developed a variety of tests for cancer detection, which are first of their kind of Asia and based on leading edge Next Generation Sequencing technology. Gene Solutions’ SPOT-MAS 10 is the first Multi Cancer Early Detection (MCED) test in Asia to provide real-world clinical evidence for cancer screening, offering the validation data needed for region-specific populations and demonstrating the test’s clinical utility. As reported in the peer reviewed journal BMC Medicine in February 2025, SPOT‑MAS ctDNA assay was evaluated in a landmark prospective cohort involving 9,024 asymptomatic Vietnamese adults, showing 70.8 % sensitivity for cancer detection (including precancerous lesions) and 99.7 % specificity, with 60 % positive predictive value for locating cancers – making it Asia’s first clinically validated multi-cancer early detection blood test.